ATE60715T1 - Verfahren zur isolation und reinigung von mit radioaktivem rhenium verknuepften pharmaka, ihre verwendung und besteck hierfuer. - Google Patents

Verfahren zur isolation und reinigung von mit radioaktivem rhenium verknuepften pharmaka, ihre verwendung und besteck hierfuer.

Info

Publication number
ATE60715T1
ATE60715T1 AT87108442T AT87108442T ATE60715T1 AT E60715 T1 ATE60715 T1 AT E60715T1 AT 87108442 T AT87108442 T AT 87108442T AT 87108442 T AT87108442 T AT 87108442T AT E60715 T1 ATE60715 T1 AT E60715T1
Authority
AT
Austria
Prior art keywords
radiopharmaceutical
perrhenate
ligand
isolation
purification
Prior art date
Application number
AT87108442T
Other languages
English (en)
Inventor
Edward A Deutsch
Harry R Maxon Iii
Karen F Libson
Alan Ketring
Original Assignee
Univ Cincinnati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cincinnati filed Critical Univ Cincinnati
Application granted granted Critical
Publication of ATE60715T1 publication Critical patent/ATE60715T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT87108442T 1986-06-13 1987-06-11 Verfahren zur isolation und reinigung von mit radioaktivem rhenium verknuepften pharmaka, ihre verwendung und besteck hierfuer. ATE60715T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/873,990 US4935222A (en) 1986-06-13 1986-06-13 Procedure for isolating and purifying radioactive ligated rhenium pharmaceuticals and use thereof and kit
EP87108442A EP0250966B1 (de) 1986-06-13 1987-06-11 Verfahren zur Isolation und Reinigung von mit radioaktivem Rhenium verknüpften Pharmaka, ihre Verwendung und Besteck hierfür

Publications (1)

Publication Number Publication Date
ATE60715T1 true ATE60715T1 (de) 1991-02-15

Family

ID=25362750

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87108442T ATE60715T1 (de) 1986-06-13 1987-06-11 Verfahren zur isolation und reinigung von mit radioaktivem rhenium verknuepften pharmaka, ihre verwendung und besteck hierfuer.

Country Status (10)

Country Link
US (1) US4935222A (de)
EP (1) EP0250966B1 (de)
JP (1) JP2502601B2 (de)
AT (1) ATE60715T1 (de)
AU (1) AU597983B2 (de)
CA (1) CA1287576C (de)
DE (1) DE3767929D1 (de)
DK (1) DK173424B1 (de)
ES (1) ES2038618T3 (de)
GR (1) GR3001669T3 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5393512A (en) * 1985-01-14 1995-02-28 Vanderheyden; Jean-Luc Stable therapeutic radionuclide compositions and methods for preparation thereof
US4897255A (en) * 1985-01-14 1990-01-30 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US5192526A (en) * 1989-05-02 1993-03-09 Mallinckrodt Medical, Inc. Kit for preparation of rhenium therapeutic agents for bone cancer without purification
US5021235A (en) * 1989-05-02 1991-06-04 Mallinckrodt, Inc. Preparation of rhenium phosphonate therapeutic agents for bone cancer without purification
WO1991004057A1 (en) * 1989-09-22 1991-04-04 Neorx Corporation Stable therapeutic radionuclide compositions and methods for preparation thereof
US7018612B1 (en) * 1990-07-06 2006-03-28 Mallinckrodt Inc. Method of preparing a radioactive rhenium complex solution
JP3370666B2 (ja) * 1990-07-06 2003-01-27 マリンクロッド・インコーポレイテッド 放射性レニウム錯体溶液の調製法
US5219556A (en) * 1990-07-09 1993-06-15 Mallinckrodt Medical, Inc. Stabilized therapeutic radiopharmaceutical complexes
US5186913A (en) * 1991-04-26 1993-02-16 Martin Marietta Energy Systems, Inc. Tungsten-188/carrier-free rhenium-188 perrhenic acid generator system
EP0513510A1 (de) * 1991-05-01 1992-11-19 E.R. SQUIBB & SONS, INC. Verfahren zur Stabilisierung von radiomarkierten biologischen Molekülen durch Verwendung von Ionenaustauschharzen
US5190735A (en) * 1992-03-30 1993-03-02 The United States Of America As Represented By The United States Department Of Energy Recovery of germanium-68 from irradiated targets
JPH0952275A (ja) * 1996-02-01 1997-02-25 Tsuneo Sugito 線条からなる板状立体空隙構造体
EP0921756A4 (de) * 1996-06-24 2003-05-21 Du Pont Merck Pharma Radiopharmazeutische verbindungen und matrizen sowie deren anwendung
US6241962B1 (en) * 1996-06-24 2001-06-05 Dupont Pharmaceuticals Company Radiopharmaceutical compositions and matrices and uses thereof
US5729821A (en) * 1996-12-10 1998-03-17 Lockheed Martin Energy Research Coirporation Concentration of perrhenate and pertechnetate solutions
US6344178B1 (en) * 1997-04-25 2002-02-05 Mallinckrodt Inc. Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates
US6844425B1 (en) 1999-02-24 2005-01-18 Mallinckrodt Inc. Combination of intercalating organometallic complexes and tumor seeking biomolecules for DNA cleavage and radiotherapy
GB0015242D0 (en) 2000-06-22 2000-08-16 Nycomed Amersham Plc Stabiliser for radiopharmaceuticals
WO2004001767A1 (en) * 2002-06-21 2003-12-31 Lynntech, Inc. Ion exchange materials for use in a bi-213 generator
JP5139678B2 (ja) * 2003-07-24 2013-02-06 ブラッコ・イメージング・ソシエタ・ペル・アチオニ 安定な放射性医薬品組成物およびその製法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2021631B2 (de) * 1970-05-02 1971-11-18 Heraeus Gmbh W C Reinigungsverfahren fuer rheniumhaltige loesungen
US4185078A (en) * 1974-09-12 1980-01-22 Gte Sylvania Incorporated Extraction process for recovery of rhenium
GB1531985A (en) * 1975-03-06 1978-11-15 Radiochemical Centre Ltd Technetium-99m
CA1169773A (en) * 1979-04-17 1984-06-26 Karel J. Panek Preparation and use of a su195m xxau-containing liquid
US4387087A (en) * 1980-04-18 1983-06-07 Research Corporation Cationic lipophilic complexes of 99m Tc and their use for myocardial and hepatobiliary imaging
US4401646A (en) * 1981-05-08 1983-08-30 University Patents Inc. Method and apparatus for purifying materials radiolabeled with technetium-99m
US4512967A (en) * 1982-08-02 1985-04-23 E. I. Du Pont De Nemours And Compamy Cationic technetium complexes useful as radiodiagnostic agents
US4440738A (en) * 1982-06-10 1984-04-03 Mallinckrodt, Inc. Stable radiographic imaging agents
US4707544A (en) * 1984-11-28 1987-11-17 President And Fellows Of Harvard College Metal-isonitrile adducts for preparing radionuclide complexes for labelling and imaging agents

Also Published As

Publication number Publication date
GR3001669T3 (en) 1992-11-23
EP0250966B1 (de) 1991-02-06
EP0250966A1 (de) 1988-01-07
JPS6354330A (ja) 1988-03-08
CA1287576C (en) 1991-08-13
DE3767929D1 (de) 1991-03-14
AU597983B2 (en) 1990-06-14
AU7376887A (en) 1987-12-17
JP2502601B2 (ja) 1996-05-29
DK299887A (da) 1987-12-14
DK299887D0 (da) 1987-06-12
ES2038618T3 (es) 1993-08-01
DK173424B1 (da) 2000-10-09
US4935222A (en) 1990-06-19

Similar Documents

Publication Publication Date Title
ATE60715T1 (de) Verfahren zur isolation und reinigung von mit radioaktivem rhenium verknuepften pharmaka, ihre verwendung und besteck hierfuer.
ATE108771T1 (de) Chelatbildner zur komplexierung von radioaktiven isotopen, deren metallkomplexe sowie ihre verwendung in diagnostik und therapie.
NL950018I2 (nl) Verbeteringen van of betrekking hebbende op nieuwe, als antivirale middelen geschikte difluorverbindingen.
SE9500724D0 (sv) Filtrering
DE3751666D1 (de) Flüssige konzentrierte Zusammensetzung zur Herstellung von Phosphatierlösungen die Mangan enthalten
AU578050B2 (en) Desulfatohirudins, the preparation thereof and pharmaceutical compositions containing them
EP0179390A3 (de) L-Lysin- und L-Histidinpyruvat
AU6567086A (en) Compositions and methods for the treatment of bleeding disorders
PT82987A (de) Neue carbonsaeurederivate verfahren zu ihrer herstellung ihre verwendung sowie arzneimittel die diese verbindungen enthalten
HU896737D0 (en) Process for the preparation of compounds useful as intermediates in the preparation of tetrazole derivatives reducing the pathologically high cholesterin level in blood
EP0119428A3 (de) Biscarboxamide zur Bekämpfung von Erkrankungen sowie Verfahren zu ihrer Herstellung
DK0532566T3 (da) Cyklopentadienylcarbonyl-99mTc-komplekser, fremgangsmåde til fremstilling af disse samt deres anvendelse i diagnostikken
ATE26213T1 (de) Aeusserlich anzuwendende arzneimittelzubereitung enthaltend adenosin zur behandlung von herpes.
SU1713591A1 (ru) Способ получени человеческого лейкоцитарного интерферона
PT83309B (de) Neue pyrrolo-benzimidazole pyrrolo-benzoxazole und pyrrolo-benzthiazole verfahren zu ihrer herstellung und diese verbindungen enthaltende arneimittel
EP0194901A3 (de) Derivate des Isoprenoidamines, Zusammensetzungen die diese enthalten, ihre Herstellung und Verwendung
DE3787958D1 (de) Abkömmlinge von (trans)- und 13-(cis)-Retionsäure sowie Verfahren zur Herstellung derselben.
DE3670485D1 (de) Verfahren zur herstellung von additionsverbindungen aus 1 mol dimerisiertem oder niedrig-oligodimerisiertem 4,4'-diisocyanatodiphenylmethan und 2 bis 3 mol 4,4'-diisocyanatodiphenylmethan, entsprechende additionsverbindungen und ihre verwendung zur polyurethanherstellung.
ATE61573T1 (de) Neue kristalline salze von aryloxypropanolaminen, verfahren zu ihrer herstellung und ihre verwendung.
ES8600758A1 (es) Procedimiento para preparar derivados de1,3-dioxolanilo
EP0223184A3 (de) Neue Cephalosporine, Verfahren zu deren Herstellung sowie ihre Verwendung als Arzneimittel
CA2058453A1 (en) Chymosin recovery and purification
ATE118773T1 (de) Verfahren zur herstellung von 2-(3-pyridyl)- tetrahydrothiopyran-2-carbonsäurethioamid-1- (1r,2r)oxyden, die so erhaltenen 2-(3-pyridyl)- tetrahydrothiopyran-2-carbothioamid-1- (1r,2r)oxyde und diese enthaltende pharmazeutische zusammenstellungen.
ATE45939T1 (de) Mischung von diastereoisomeren verbindungen, erhalten aus (-)-5-(1-hydroxy-1-methylaethyl)-2methyl-2-cyclohexen-1-on mit mucosecretolytischer wirkung, ihr herstellungsverfahren und diese enthaltende pharmazeutische kompositionen.
FR2541270B1 (fr) Procede de preparation de melanges chelates de l'acide ethylenediamine n,n'-di (p-hydroxyphenylacetique)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee